Executive Committee

The Alliance Executive Committee is chaired by the Group Chair and includes the Group Vice Chair, Program Directors, and eight representatives elected from the Board of Directors, including four Principal Investigators from academic member institutions and four Principal Investigators from community member institutions. The Executive Committee sets the scientific agenda of the Group by approving protocols at the concept stage. In addition, the Executive Committee approves the appointment of the Chairs of the Disease and Modality committees and is responsible for the management of Group affairs.

Monica M. Bertagnolli, MD
Chair
Suzanne George, MD
Vice-Chair

PROGRAM PRINCIPAL INVESTIGATORS
Jan C. Buckner, MD
Cancer Control Program
Gini F. Fleming, MD
Central Protocol Operations Program
Kelly K. Hunt, MD
American College of Surgeons Clinical Research Program
Sumithra J. Mandrekar, PhD
Statistics and Data Management Program
W. Fraser Symmans, MD
Translational Research Program

BOARD OF DIRECTORS REPRESENTATIVES
Harold J. Burstein, MD, PhD
Dana-Farber / Partners CancerCare LAPS
Jeffrey Crawford, MD
Duke University - Duke Cancer Institute LAPS
Hedy L. Kindler, MD
University of Chicago Comprehensive Cancer Center
A. Marilyn Leitch, MD
University of Texas Southwestern Medical Center LAPS
Benjamin T. Marchello, MD
Montana Cancer Consortium NCORP
Gary K. Schwartz, MD
Columbia University Minority Underserved NCORP
Philip J. Stella, MD
Michigan Cancer Research Consortium NCORP
Gary W. Unzeitig, MD
Doctor’s Hospital of Laredo

AD HOC REPRESENTATIVES
Richard M. Goldberg, MD
Cancer Center Collaborations
Steven Piantadosi, MD, PhD
Strategic Initiatives and Innovation
Patty Spears
Patient Advocacy
Mark A. Watson, MD, PhD
Biorepository Systems